Cardiovascular Risk in HIV

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-08-02
Clinical Trial Update: Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated [Phase 4]
Phase 4 trial update examining the effects of losartan combined with an antiretroviral regimen containing raltegravir on fibrosis, inflammat…